FROM EDUCATION TO TUMOUR CHARACTERISTICS IN COLORECTAL CANCER: AN ANALYSIS OF THE PATHWAYS

Size: px
Start display at page:

Download "FROM EDUCATION TO TUMOUR CHARACTERISTICS IN COLORECTAL CANCER: AN ANALYSIS OF THE PATHWAYS"

Transcription

1 FROM EDUCATION TO TUMOUR CHARACTERISTICS IN COLORECTAL CANCER: AN ANALYSIS OF THE PATHWAYS By Parisa Airia A thesis submitted in conformity with the requirements for the degree of PhD Dalla Lana School of Public Health University of Toronto Copyright by Parisa Airia 2013

2 From education to tumour characteristics in colorectal cancer: an analysis of the pathways Abstract Parisa Airia Doctor of Philosophy Dalla Lana School of Public Health University of Toronto 2013 Background: Genetic and environmental factors have been associated with colorectal cancer (CRC) risk. However, their association with prognosis has been less studied. Methods: Path analysis was employed to examine causal pathways from education to environmental (diet, alcohol, smoking, physical activity) and personal factors (screening), and then to obesity and ultimately to tumour characteristics (stage, grade, microsatellite instability (MSI), and site) that are associated with CRC prognosis. Data came from the Ontario Familial Colon Cancer Registry. Pathways were evaluated for effect modification by sex and two indicators of CRC genetic susceptibility (Bethesda criteria and newly identified familial cancer clusters). Results: Four food patterns (healthy foods, high-fat foods, sweet and processed foods, and oriental foods) and four nutrient patterns (total macronutrient, fat vs. carbohydrate, and micronutrients from supplements and from foods) were identified. Education was associated positively with healthy lifestyle factors (e.g. healthy foods factor) and negatively with unhealthy factors (e.g. smoking). As expected, high body mass index (BMI) was associated with lower physical activity and higher fat vs. carbohydrate factor. Unexpectedly, BMI was positively associated with the healthy foods factor among Bethesda positive patients and men. An association between education and BMI was mediated by the healthy foods factor and by physical activity. Important poor prognostic factors, higher grade and stage, were associated with smoking and not being screened. However, unexpected associations included a positive ii

3 association of physical activity with tumour grade among Bethesda positive patients and a positive association of healthy foods with stage among Bethesda negative patients. Patients with right-sided tumours were more likely to receive micronutrients from supplements, and screening and less likely to smoke, and for men, to have a high BMI, high fat diet and healthy food diet. Conclusion: Some unhealthy lifestyle factors, such as smoking and a high fat food dietary pattern, are associated with adverse CRC tumour characteristics and so may affect the prognosis. Family history may modify some associations though the findings require independent confirmation. iii

4 Acknowledgments I would like to thank my thesis supervisor, Dr. Gail Eyssen, for her support, patience, advice and guidance throughout my studies and for the countless hours of her time that she contributed to this thesis. I would like to extend my heartfelt thanks to all my committee members, Drs. Pierre Cote, Loraine Marrett, Andrew Seary, and Steven Gallinger for all their support and contributions without whose help I could not complete this thesis. I will also remain indebted to Drs. Elizabeth Badley, Anthony Miller, John McLaughlin, and Polly Newcomb for reviewing my thesis and providing me with their invaluable input. Many thanks to Darshana Daftary and Dr. Michelle Cotterchio and Rose Sarvaria for patiently responding to my questions and helping me with obtaining and understanding my data. This thesis is dedicated to my parents, my daughter, and my sister. Words fail to express my gratitude to my parents Azam Malekzadeh and Daryoush Airia for their unending love and support, beyond imagination, who made it possible for me to continue my studies under all life circumstances; and to my amazing daughter Roxana for her patience and for sacrificing her fun and her time with me to make it possible for me to complete this work. Thanks to my sister, Atoosa, for her continuous emotional support throughout my life. iv

5 Table of Contents Acknowledgments... iv Table of Contents... v List of Tables... xi List of Figures... xiv List of Appendices... xv Chapter 1. Introduction Background Research Problem Study Objectives Importance of this Study... 9 Chapter 2. Literature Review Introduction Tumour characteristics related to CRC survival Clinicopathologic tumour characteristics Stage Grade Site Genetic tumour characteristics Chromosomal Instability pathway (CIN) or microsatellite stable (MSS) Microsatellite Instability (MSI) Familial patterns related to the occurrence of CRC HNPCC (Hereditary Non-Polyposis CRC) Newly identified familial clusters of CRC and other cancers v

6 2.4 Personal factors associated with CRC incidence and survival Diet in relation to CRC incidence and survival Diet and CRC incidence Diet and CRC survival Diet and tumour characteristics Physical activity in relation to CRC incidence and survival Physical activity and CRC incidence Physical activity and CRC Survival Obesity in relation to CRC incidence and survival Obesity and CRC incidence Obesity and CRC Survival Socioeconomic Status (SES) in relation to CRC incidence and survival SES and CRC incidence SES and CRC survival Screening in relation to CRC incidence and survival Screening and CRC incidence Screening and CRC survival Smoking in relation to CRC incidence and survival Smoking and CRC incidence Smoking and CRC survival Age and CRC survival Sex and CRC survival Measurement issues Issues with the measurement of tumour characteristics Tumour grade vi

7 MSI and its associated genetic mutations Tumour site Tumour stage Issues with the measurement of obesity Issues with the measurement of physical activity Issues with the measurement of diet Issues with the measurement of SES Pathways to tumour characteristics Possible mechanisms for the association of Lifestyle factors and CRC Chapter 3. Methods Introduction Study Design Study Sample Structure and methods of OFCCR Cases Family members Controls Data collection and Variable definitions Personal history questionnaire (PHQ) Physical activity Smoking BMI Screening Demographic characteristics (SES, age, sex) Family history questionnaire vii

8 Family history The food frequency questionnaire Alcohol consumption Dietary patterns Review of medical records Grade Stage Site MSI Analysis Data cleaning Descriptive analysis Principal component analysis Distribution of data Analysis of associations Standard analysis Path Analysis Chapter 4. Results Introduction Descriptive Analysis Distribution of the variables Principal Component Analysis Food Patterns Nutrient Patterns Summary of Section viii

9 4.3 Network Analysis for Identifying Familial Clustering Standard Analysis of Associations Associations among lifestyle factors Association between education and lifestyle factors Associations among education, lifestyle and personal factors and BMI and tumour characteristics Associations with BMI Summary of associations with tumour characteristics Detailed associations with tumour characteristics Path analysis Comparison of the results of Path analysis and Standard analysis Summary of the section Chapter 5. Discussion Introduction Identified dietary patterns Limitations of the identified patterns Associations among lifestyle factors Relationship of Education with diet, other lifestyle factors, and screening Education with diet Education with other lifestyle factors Education with screening Predictors of BMI Diet Lifestyle factors Education Mediated pathways to BMI ix

10 5.6 Predictors of tumour characteristics Predictors of tumour Grade Predictors of tumour MSI Predictors of tumour site Predictors of tumour stage Summary Comparison of results of path analysis with standard analysis Study limitations Data limitations Design limitations Analysis limitations Implications of the study Recommendations for Future Research References x

11 List of Tables Table 2.1 Dukes system and its association with TNM system [71] Table 2.2 Distribution of colon and rectal cancer [75] Table 2.3 Clinicopathologic differences between MSI-H and MSS tumours [43] Table 2.4 Clinicopathologic differences between MSI-H tumours in sporadic and HNPCC cases [43] Table 2.5 Frequency of MSI and MSS tumours [43] Table 2.6 Amsterdam criteria I and II for HNPCC [43] Table 2.7 Bethesda Guidelines for MSI Testing: Tumours From Any of the Following Should be Tested for MSI (by immunohistochemistry) and Then Positive Patients Should Continue for MMR Testing [128] Table 2.8 Modified Bethesda Guidelines for MSI Testing: Tumours From Any of the Following Should be Tested for MSI (by immunohistochemistry) and Then Positive Patients Should Continue for MMR Testing [128] Table 2.9 Newly identified familial clusters of CRC Table 2.10 Nnutritional factors associated with CRC risk Table 2.11 Strength of associations between foods/nutrients and CRC risk: results of metaanalyses or range of estimates from individual studies when meta-analysis has not been performed [19] Table 2.12 Dietary Patterns associated with CRC/Adenoma risk Table 3.1 Regression methods used for the analysis of associations Table 4.1: Mean and frequency distribution of variables in the grade sample xi

12 Table 4.2: Component matrix showing the component score coefficients for each food item loading on the first food pattern (healthy foods) in grade sample Table 4.3: Component matrix showing the component score coefficients for each food item loading on the second food pattern (high-fat foods) in grade sample Table 4.4: Component matrix showing the component score coefficients for each food item loading on the third food pattern (Oriental foods) in grade sample Table 4.5: Component matrix showing the component score coefficients for each food item loading on the fourth food pattern (Sweet and processed foods) in grade sample Table 4.6: Component matrix showing the component score coefficients for each macronutrient loading on the first macronutrient pattern (total macronutrients) in grade sample Table 4.7Component matrix showing the component score coefficients for each macronutrient loading on the second macronutrient pattern (fat vs. carbohydrate) in grade sample Table 4.8: Component matrix showing the component score coefficients for each micronutrient loading on the first micronutrient pattern (total micronutrients from food) Table 4.9: Component matrix showing the component score coefficients for each micronutrient loading on the first micronutrient pattern (total micronutrients from food) in grade sample Table 4.10 Newly identified familial clusters of CRC Table 4.11: Association of education and continuously measured life-style factors (beta from linear regression models) in grade sample, N= Table 4.12: Association of education and binary life-style factors (odds ratio or exponential of beta from logistic regression models) in grade sample, N= Table 4.13: Education, lifestyle factors, food patterns in association with BMI, considering effect modification by Bethesda family history, sex, and familial clustering of cancer in the grade tumour sample xii

13 Table 4.14: Education, lifestyle factors, nutrient patterns in association with BMI, considering effect modification by Bethesda family history, sex, and familial clustering of cancer in the grade tumour sample Table 4.15: Comparison of significant or borderline associations among all variables between standard and path analysis in Grade sample (n=926), including food patterns, and considering Bethesda interaction Table 4.16: Comparison of significant or borderline associations among all variables between standard and path analysis in Grade sample (n=926), including food patterns, and considering sex interaction Table 4.17: Comparison of significant or borderline associations among all variables between standard and path analysis in Grade sample (n=926), including food patterns, and considering familial clustering interaction Table 4.18: Comparison of significant or borderline associations among all variables between standard and path analysis in Grade sample (n=926), including nutrient patterns, and considering Bethesda interaction Table 4.19: Comparison of significant or borderline associations among all variables between standard and path analysis in Grade sample (n=926), including nutrient patterns, and considering sex interaction Table 4.20: Comparison of significant or borderline associations among all variables between standard and path analysis in Grade sample (n=926), including nutrient patterns, and considering familial clustering interaction xiii

14 List of Figures Figure 1-1: Assumed pathways of associations between the modifiable lifestyle and personal factors and survival from CRC. 2 Figure 1-2 Conceptual Model 9 Figure 4-1: Association among education, personal and life style factors including food patterns and BMI in Grade sample. 115 Figure 4-2: Association among education, personal and life style factors including nutrient patterns and BMI in Grade sample. 116 Figure 4-3: Association of education, lifestyle and personal factors including screening and BMI with tumour grade. 126 Figure 4-4 Association of education, lifestyle and personal factors including screening and BMI with tumour site. 129 Figure 4-5 Association of education, lifestyle and personal factors including screening and BMI with tumour stage. 130 Figure 5-1: Assumed pathways of associations between the modifiable lifestyle and personal factors and survival from CRC. 183 xiv

15 List of Appendices Appendix 1: Case recruitment in OFCCR Appendix 2: Family Member Recruitment in OFCCR Appendix 3: Control Recruitment in OFCCR Appendix 4: Data cleaning procedures for food/nutrient variables Appendix 5: Mean and frequency distribution of variables Appendix 6: Frequency distribution of familial clusters within each tumour characteristic sample Appendix 7: Average daily intake of important dietary items within each of the tumour characteristic samples Appendix 8: Food patterns and food items loading on them in MSI, Site, and Stage tumour characteristic samples Appendix 9: Micro- and macro-nutrient patterns and nutrients loading on them in MSI, Site, and Stage tumour characteristic samples Appendix 10: Correlation of principal component scores between the largest sample vs. tumour characteristic subsamples Appendix 11: Correlation of dietary principal component scores among different tumour characteristic samples Appendix 12: Statistically significant correlations among lifestyle and personal factors in the four tumour characteristic samples Appendix 13: Association of education with life style factors in the four tumour characteristic samples xv

16 Appendix 14: Association of BMI with education, lifestyle and personal factors in the four tumour characteristic samples Appendix 15: Association of the variables with tumour grade in standard analysis Appendix 16: Association of the variables in with tumour MSI in standard analysis Appendix 17: Association of the variables with tumour site in standard analysis Appendix 18: Association of the variables with tumour stage in the standard analysis Appendix 19: Association of the variables in the models including tumour grade in the path analysis Appendix 20: Association of the variables in the model including tumour MSI in the path analysis Appendix 21: Association of the variables in the model including tumour site in the path analysis Appendix 22: Association of the variables in the model including tumour stage in the path analysis Appendix 23: Summary and comparison of the results from standard analysis and path analysis Appendix 24: Correlations (r: Pearson correlation coefficient) among food and nutrient patterns in four samples Appendix 25: Distribution of variables by sex and Bethesda status in Grade sample (N=926). 351 Appendix 26: Scatter plot of BMI versus alcohol consumption per month in grams in the grade sample Appendix 27: The association of tumour grade with BMI categorized as >=25 or <25, among men and women xvi

17 Appendix 28: The association of tumour grade with physical activity, among Bethesda positive and Bethesda negative Appendix 29: The association of tumour stage with healthy food pattern, among Bethesda positive and Bethesda negative xvii

18 1.1 Background Chapter 1. Introduction Colorectal cancer (CRC) is the second leading cause of cancer death in Canada [1]. It is estimated that in 2012, 23,300 Canadians will be diagnosed with CRC (an age-standardized incidence rate of about 50 per 100,000 Canadian population) and 9,200 will die of it (an agestandardized mortality rate of about 20 per 100,000 Canadian population) [1]. Among men, one in 13 is expected to develop CRC during their lifetime and one in 28 will die of it; among women, one in 16 is expected to develop CRC during their lifetime and one in 32 will die of it [1]. Moreover, the prognosis of CRC is poor when compared to some other common cancer diagnoses in Canada, e.g. breast and prostate cancer, with only about 63% 5-year relative survival rate for colorectal cancer compared to 88% and 96% for breast and prostate cancer respectively [1] and [2]. Much of the research has focused on recognizing and addressing risk factors of CRC and this is very valuable. Several genetic and environmental factors (including diet, alcohol, smoking, physical activity, and obesity) have been associated with CRC risk. However, given the poor prognosis of CRC, there is a need to better understand the modifiable factors associated with prognosis of CRC. Factors have been identified which are associated with the prognosis of CRC. Factors associated with prognosis include both biologic characteristics of tumours (grade, stage, and site of the tumour, and presence of microsatellite instability (MSI) [3]-[9]); and lifestyle and personal characteristics (aspects of diet, physical activity, alcohol, smoking, obesity, screening, SES, sex, family history, and age at diagnosis, [10]-[16]). This investigation will determine whether these prognostic biologic tumour characteristics are associated with lifestyle and personal characteristics, and will investigate for the first time pathways through which they are associated. 1.2 Research Problem Where survival data are available, factors associated with prognosis are best identified through studies of their association with survival from CRC. However, prognosis with CRC is strongly strong associated with biologic tumour characteristics (stage. grade, MSI, and tumour site) [17]. Therefore, where survival data are not available, an alternative approach is to study factors 1

19 2 associated with poor prognostic biologic characteristics of CRC. This study will adopt the latter approach, as survival data were not available. The importance of this study to understanding of pathways 1 among factors influencing survival, rests on evidence, supported by detailed review in Chapter 2, that prognostic tumour characteristics in this investigation are associated with survival from CRC [17] and on the assumption that, as shown in Figure 1-1, these prognostic characteristics are mediators 2 of the association between lifestyle/personal factors and survival (solid lines in Figure 1-1). However, as also shown in Figure 1-1 (dotted line), it is possible that an association of modifiable lifestyle and personal factors to survival occurs through other pathways which do not involve prognostic tumour characteristics. Modifiable lifestyle and personal factors Prognostic tumour characteristics CRC survival Figure 1-1: Assumed pathways of associations between the modifiable lifestyle and personal factors and survival from CRC. This hypothesized model shows both direct (dotted lines) and mediated (solid lines) pathways from the predictor variables to tumour characteristics. The associations described in the figure could ideally be investigated in a prospective cohort study of cancer-free individuals with a sample size that would allow sufficient incident cancer with various clinical characteristics to occur. However, a cost-effective design would be a prospective study of cases followed to assess survival. In such a study, pre-diagnostic lifestyle would need to be recalled by the cases at the time of recruitment and participants would then be 1 Seauqence of associations generally for considering the intermediate variables that exist in the association of an exposure to an outcome variable, e.g. the pathway from education to BMI may include physical activity and healthy diet. It means that education may affect body weight through its association with physical ctivity and a healthy diet. 2 Mediation refers to a causal pathway in which the independent variable affects the mediator which in turn affects the outcome.

20 3 followed to assess their survival. The cases recruited into the Ontario Familial Cancer Registry (OFCCR) form such a cohort of cases. Therefore, the present study is conceived as a cohort study of cases to evaluate the first step in a pathway between lifestyle and survival, mediated by prognostic clinical tumour characteristics. It therefore evaluates the association of lifestyle and other factors to prognostic characteristics. Because no information on survival was available when the investigation began, it is not possible to examine the association of clinical characteristics to survival, the second step in the mediated pathway shown in the figure, or any direct associations of lifestyle and other factors to survival. The choices for study of prognostic clinical characteristics (grade, stage, microsatellite instability (MSI), and tumour site) and of the lifestyle and other factors (education, diet, smoking habit, alcohol use, physical activity, body mass index (BMI) and colorectal cancer screening) are outlined below and are fully justified in the literature review in Chapter 2. To our knowledge, the study is innovative in four ways. It is the first study to examine the association of lifestyle with grade. It is also the first study to investigate causal pathways among the concepts under study, and to investigate, where appropriate, the modification of these pathways by sex and family history of cancer. Although some previous studies have considered dietary patterns, rather than individual foods and nutrients, in investigations of CRC risk and one study has considered the association of dietary patterns and CRC survival, none has considered the association of patterns of food and nutrient intake with measures of tumour aggression. Finally, this study has compared in practical circumstances the results obtained through two types of analysis for the investigation of mediated pathways, as well as comparing these with the findings of conventional analysis in which mediated pathways cannot be detected. The choice of prognostic clinical characteristics for this study is based on the evidence (reviewed in Chapter 2) that higher tumour stage, higher tumour grade, microsatellite stable tumours, and more distal (distal colon and rectal) tumours in CRC are associated with worse survival from CRC. These prognostic characteristics reflect different aspects of tumour biology, but each is associated with prognosis. Tumour stage reflects the spread of the disease and hence indicates a more advanced disease [17]. Tumor grade indicates a biologically aggressive tumour [17]. Rectal cancers have poorer prognosis than colon cancer [2]; they may also have different risk factors and are less commonly associated with genetic and familial factors, compared to proximal

21 4 tumors [18]. Proximal colon cancers have the best prognosis compared to those in other locations in the large bowel [2]. Microsatellite stable tumours are associated with worse prognosis than microsatellite instable tumours [7]. The underlying association being investigated is that unhealthy lifestyle factors may be associated with more biologically aggressive tumours which are associated with lower rates of survival. Although there is a large body of literature on the association between lifestyle and personal factors and risk of CRC, e.g. [19], few studies have examined the association of these factors with survival from CRC [21]-[26] and their results have not been conclusive. There are no studies to our knowledge that have examined pathway of associations with prognostic characteristics of colorectal tumours, although association of individual risk factors have been studied for tumour stage, e.g. [27], [28], tumour location e.g. [18], and MSI [29]-[34]. Moreover, most dietary studies have used single dietary factors or nutrients rather than dietary pattern. Since people consume different foods and nutrients in combination, it is difficult and sometimes impossible to measure the effect of an individual food or nutrient when its consumption is highly correlated with other foods or nutrients. Therefore, studying the food or nutrient patterns in different individuals should better reflect the effect of such combinations when they happen to be very closely related. Obesity is a risk factor for CRC which is associated with each of diet, alcohol, smoking and physical activity [23], [19]. Given that obesity is known to be associated with survival from CRC, e.g. [24], it may mediate an association between these lifestyle risk factors and survival. Moreover, obesity may affect survival through its association with prognostic tumour characteristics. To our knowledge, no studies have examined the association between obesity and prognostic characteristics of colorectal tumours. Socioeconomic status (SES) is another factor that has been associated with survival from CRC, with low SES being associated with poorer survival, e.g. [25]. This may occur because SES is associated with lifestyle factors, such as diet, alcohol intake, smoking and physical activity [35]- [38], factors which, as explained above, may themselves be associated with survival. SES is also associated with screening, with those of lower SES less likely to be screened than those of higher

22 5 SES [39]. Lack of screening results in higher stage at diagnosis and lower survival [26]. These observations suggest a mediating role for lifestyle and screening in the association between SES and CRC survival. Thus low SES may be associated with high-risk lifestyle and lack of screening, and these lifestyle and personal factors could reduce survival. SES is often considered as a potential confounder of associations between risk factors and disease [40] but this does not allow a full understanding of the pathways to disease. To my knowledge, full sequential associations or pathways from SES to lifestyle and other factors, to disease have never been investigated. This study will investigate such pathways among colorectal cancer patients, but will consider whether pathways seen among cases are likely to apply in the general population. Although SES is not itself a modifiable factor, its correlates, high-risk lifestyle and lack of screening, are modifiable. Therefore, identifying a role for SES in CRC prognosis, together with the pathways involved, could assist in focusing public health interventions to the vulnerable populations if appropriate and in targeting key lifestyle and personal factors. In addition to modifiable factors which may influence both the risk and prognosis of CRC, there are factors which may modify 3 the associations of these modifiable factors with risk/prognosis. This study will focus on sex and on family history of disease. Sex influences the association of lifestyle factors and risk of developing colorectal cancer [19], as well as survival after the disease has occurred [18]. For example, the report on Food, Nutrition, Physical Activity and the Prevention of Cancer by the World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) suggests that some lifestyle factors such as alcohol have stronger association with CRC risk among men compared to women [19] or another study showed a diet high on processed meat is associated with lower survival from CRC more strongly among women than men [41]. Therefore, sex may also modify the relationships between CRC risk and prognosis and lifestyle and personal factors. 3 Effect modification in this context refers to difference in associations of an exposure and outcome depending on the level of a third variable, an effect modifier variable. An example is the difference in associations found among men and women.

23 6 Two specific types of familial clusters with a high risk of CRC have been recognized, Familial Adenomatous Polyposis (FAP) and Hereditary Non-Polyposis CRC (HNPCC) [46], [47] for which associated genes have been identified. FAP is an inherited mutation in APC gene which accounts for less than 1% of CRCs in North America [124]. The mutation leads to the formation of thousands of colorectal polyps and causes a high risk of CRC (nearly 100% by age 35-40) [124]. It is not considered further in this thesis because of its low prevalence and strong genetic etiology, as well as because FAP was an exclusion criterion for cases in the Ontario Familial Colorectal Cancer Registry on which this study is based. HNPCC is a syndrome of familial susceptibility to CRC and certain other cancers (endometrium, ovary, kidney, brain, stomach, lymph, pancreas, liver [48]) thought to be inherited in an autosomal dominant pattern and result from inherited mutated mismatch repair genes [106]. It accounts for about 5% of colorectal cancer cases [43]. Despite the high risk of CRC in HPCC families, prognosis of tumours in these families is better than that in the general population [44] and it is possible that modifiable lifestyle factors may affect prognosis in people with HNPCC genes differently than in people without them, a so-called gene-environment interaction [52]. A recent study [51] has identified additional familial clusters of CRC and other cancers. The newly identified familial clusters observed co-occurrence of extra-colonic cancer sites not previously considered in HNPCC and suggested that the nature of cancers seen in familial clusters may differ for families with predominantly 1) colon and rectal cancers, and 2) cancers of the left and right colon. In addition, there were cases who reported a family history but in whom no particular patterns of cancer occurrence were observed. Taken together, these clusters of familial susceptibility indicate the potential for genes or environmental factors which cluster in families to be associated with risk, as well as the possibility of an interaction of genetic and environmental factors in determining cancer risk or prognosis. In addition, because members of families with a history of colorectal cancer may wish to reduce their risk, it is possible that family membership may influence behaviour, such as lifestyle choices or the use of colorectal cancer screening [42], and that such behaviour may cause the presence of a family history to modify associations seen between risk factors and CRC risk and/or prognosis.

24 7 1.3 Study Objectives Primary objective (Figure 1-2 Conceptual Model): 1. To examine among colorectal cancer patients the pathways of association between education, lifestyle (diet, physical activity, smoking and drinking) and personal factors (screening and obesity) and prognostic tumour characteristics in CRC, controlling for any confounding effect of age, and with consideration of the possible effect modification by sex and the presence of a family history of colorectal cancer satisfying Bethesda criteria. The specific hypotheses being tested in Primary Objective 1 include evaluation of whether among colorectal cancer patients: (i) Education (as an indicator of SES) is associated with lifestyle factors including physical activity, diet, smoking, and drinking and personal factors including screening and obesity. (ii) Lifestyle factors including physical activity, diet, smoking, and drinking and personal factors including screening are associated with obesity. (iii) Lifestyle factors including physical activity, diet, smoking, and drinking and personal factors including screening and obesity, as well as education, are associated with prognostic CRC tumour characteristics (grade, MSI, stage, and site). (iv) Lifestyle factors including physical activity, diet, smoking, and drinking and personal factors including screening mediate the association between education and obesity in this patient population. (v) Obesity mediates the association between life style factors including physical activity, diet, smoking, and drinking and personal factors including screening and CRC prognostic tumour characteristics (grade, MSI, stage, and site).

25 8 (vi) Lifestyle factors including physical activity, diet, smoking, and drinking and personal factors including screening and obesity mediate the association between education and prognostic CRC tumour characteristics (grade, MSI, stage, and site). (vii) Sex or family history satisfying Bethesda criteria for familial CRC modify associations that exist with prognostic CRC tumour characteristics (grade, MSI, stage, and site). In order to achieve these objectives, measures of diet are required. The following additional descriptive objective is therefore part of Primary Objective 1. viii) To identify patterns of consumption of foods and patterns of consumption of nutrients among cases in this study. Secondary Objective: 1. To compare in a practical situation with real data the results of two methods of analysis for investigating mediated pathways, with their associated software. The approaches are a) a standard approach to analysis using SPSS software, (here referred to as standard method) in which defined criteria of mediation are evaluated through a series of independent regression analyses; b) Path analysis using the specifically designed software for this type of analysis (Mplus) in which all pathways are estimated simultaneously. 2. To compare findings from these analyses not only with each other but also with conventional analysis which cannot detect mediated pathways because it treats relevant variables as confounders. Tertiary Objective: The final objective is hypothesis generating: 3. To determine whether newly recognized patterns of familial clusters of cancer modify associations between diet, obesity and prognostic characteristics of colorectal cancer.

26 9 Figure 1-2 depicts our hypothesized associations. However, we acknowledge that other pathways may exist that are not the focus of this thesis. All these other pathways will be included in the direct path. Dietary Patterns Education Alcohol Smoking BMI Tumour characteristic Screening Physical activity Family history and sex Figure 1-2 Conceptual Model This hypothesized model shows both direct (dotted lines) and mediated (solid lines) pathways from the predictor variables to tumour characteristics. All pathways, except those between SES and lifestyle, are potentially modified by family history and sex. All correlations among lifestyle factors are hypothesized but have not been shown in this graph for ease of demonstration. 1.4 Importance of this Study To our knowledge, no published studies have examined the sequence of pathways of associations between education, diet and other lifestyle and personal factors, obesity, and the prognostic

27 10 tumour characteristics in CRC, or how such associations may be modified by family history of cancer and sex. Understanding the association between modifiable lifestyle factors and tumour characteristics which affect survival from CRC, could lead to consideration of possible social and biological mechanisms through which lifestyle may be associated with survival from CRC. The results could have important implications in improving survival from colorectal cancer which is currently poor. The opportunity to perform this study is provided by OFCCR, a large population-based colon cancer familial registry with sufficient sample size to test multiple effects and interactions. Also, the wealth of information collected by this registry provides a rare opportunity for research in this field. The investigation of nutrient and food patterns in dietary data available through the OFCCR gives us the opportunity to identify the importance of combinations of foods or nutrients reflected by eating patterns. The use of pathway analysis allows identification of the pathways through which risk factors such as diet may affect tumour characteristics. This is a newly emerging area in the field of epidemiology which examines the pathways rather than controlling for different factors that may mediate causal pathways as confounders and thereby avoids potentially misleading conclusions (such as concluding absence of an association after controlling for a mediating variable when in fact there is a mediated association). We also have the advantage of using the information on newly identified familial clusters [51] to generate new hypotheses. These new familial clusters among colorectal cancer and other cancer sites raise the possibility of a role in colorectal carcinogenesis for presently unknown genetic factors and for environmental factors that are shared among these families. Therefore, this study could provide important clues to gene-environment interaction in predicting prognostic tumour characteristics.

28 2.1 Introduction Chapter 2. Literature Review In this chapter, I have reviewed the literature on the following topics and have identified gaps in the literature that justify the importance of this thesis. The topics include: A review of tumour characteristics related to CRC survival A review of familial patterns related to the occurrence of CRC A review of personal and lifestyle factors associated with incidence and survival from CRC Measurement issues with the variables in this study Pathways to CRC Methods of analysis of pathways 2.2 Tumour characteristics related to CRC survival Two groups of tumour characteristics have been recognized as important predictors of survival from CRC: clinicopathologic and genetic factors. The strong association between these factors and survival from CRC shows the importance of studies designed to identify the predictors of these tumour characteristics Clinicopathologic tumour characteristics Stage Stage reflects the degree of spread of a cancer in adjacent tissues and the body [67]. Stage, including clinicopathologic and pathologic stage, is a generally accepted prognostic factor in 11

29 12 CRC [68]. The local extension of the tumour and the involvement of the surgically removed regional lymph nodes are generally determined through pathologic studies. These results are referred to as pathologic stage [69]. However, distant metastasis of the tumour is usually suspected clinically and confirmed through radiological studies [70]. Dukes introduced a staging system in 1932 [70] which has been modified over time and is still the most commonly used clinicopathologic staging system in CRC. The TNM (Tumour, Node, Metastasis) system is another classification tool for different cancers which uses tumour, lymph node, and metastasis status to define the stage of a cancer [71]. Table 2.1 shows the association between Dukes system and TNM classification [72]. Table 2.1 Dukes system and its association with TNM system [72] DUKES STAGING SYSTEM CORRELATED WITH TNM SYSTEM Dukes A T1, N0, M0 (stage I) T2, N0, M0 (stage I) Dukes B T3, N0, M0 (stage II) T4, N0, M0 (stage II) Dukes C T (any), N1, M0; T (any), N2, M0 (stage III) Dukes D T (any), N (any), M1 (stage IV) T1: cancer grown through muscularis mucosa and extends into submucosa; T2: cancer grown through submucosa, and extends into muscularis propria; T3: cancer grown completely through muscularis propria into subserosa but not neighbouring organs or tissues; T4: cancer spread completely through wall of the colon or rectum into nearby tissues or organs; N0: No lymph node involvement; N1: 1-3 nearby lymph nodes involved. N2: >=4 nearby lymph nodes involved. M0: No distant spread; M1: Distant spread. It has been repeatedly shown that pathologic stage is an important predictor of recurrence, [73], and clinicopathologic stage is an important predictor of survival [17] in CRC patients. The College of American Pathologists Consensus Statement of 1999 recognized pathologic stage as a proven prognostic factor in CRC [74]. The median 5-year survival rates in different studies are as follows: for Dukes A and B, 89.9%; for Dukes C, 69.6%; and for Dukes D 11.9% [76].

30 Grade Grade is another important tumour characteristic that reflects the degree of differentiation of tumour cells and is determined through pathologic examination of the tumour [67]. Several studies have found that poor differentiation is an indicator of poor prognosis in CRC, [77]-[80]. In 1999, the College of American Pathologists Consensus Statement suggested that tumour grade is a valid prognostic indicator for CRC [74]. Most systems divide tumours into 4 categories: grade 1 (well differentiated), grade 2 (moderately differentiated), grade 3 (poorly differentiated), and grade 4 (undifferentiated) and many studies collapse this into low grade (Grade 1 and 2) and high grade (Grade 3 and 4) [71]. The College of American Pathologists, however, recommends a two-tiered grading system in order to increase consistency among studies [74]. This suggestion was supported by a large Korean study of 2230 patients which showed that the 5-year survival rates of different tumour grades, after controlling for other important prognostic factors in CRC, were as follows: grade 1, 66.5%; grade 2, 62.5%; grade 3, 50%; and grade 4, 51% [83] Site Site of the tumour is another prognostic factor in CRC, though not as strongly predictive of survival as stage and grade. Several studies have shown that overall, rectal cancer has a worse prognosis than colon cancer [77], [82]-[84]. However, individual studies vary in their findings of which site has the best/worst prognosis. One study found that left colon cancer had the best prognosis and rectal cancer had the worst, with right colon being in the middle, [82], while another found that right colon cancer had the best prognosis, followed by left colon and rectal cancer [84]. What is more consistently shown in studies is the worse prognosis of rectal cancer [77]. However, the lower survival rate of rectal cancer compared to proximal colon cancer seems to have disappeared in more recent years, with a significantly lower 5-year relative survival rate for rectal cancer compared to proximal colon cancer in reaching almost same survival rates in [1]. This has been attributed to decreasing gap between poor prognosis Microsattellite Stable (MSS) tumours (which are more often distal) compared to generally better prognosis MSI-H tumours (which are usually proximal) due to a better response of MSS tumours to new adjuvant chemotherapeutic agents like 5-fluorouracil [123].

31 14 Location of tumour differs by sex. Among women, the most common site is proximal colon or right-sided cancers (42% of all cases) followed by rectal and distal colon or left-sided cancers (28%) and (22%), respectively. Among men, the most common site is rectal cancer (38% of all cases), followed by proximal (31%) and distal colon cancer (25%) [76]. Proximal location in this report was defined as all colon cancers from cecum up to the end of splenic flexure; distal colon was defined as after splenic flexure up to the end of sigmoid colon; and rectal included all cancers of rectum and rectosigmoid junction [76]. Table 2.2 Distribution of colon and rectal cancer [76]. Site Women (%) Men (%) Proximal colon Distal colon Rectum In addition to female sex, older age and black non-hispanic race have been associated with a greater likelihood of developing CRC in a proximal location [86]. As these factors are associated with participation in screening programs [89], it is possible that screening may account for some of the shift from distal to more proximal locations in the colon which has been seen in the past two decades [85]-[88]. The incidence of rectal tumours has decreased by about 0.9% per year from 2000 to 2007, while the incidence of proximal tumours increased on average by 0.3% per year[1]. Therefore, the increased relative prevalence of proximal colon tumours may be associated with participation in screening programs and removal of the distal adenomas through proctosigmoidoscopy[76]. As screening may be important in determining tumour location as well as grade and stage it will be important to consider its role in studies designed to investigate the relationship between lifestyle and clinical factors related to prognosis. In summary, studies that have looked at the relative importance of clinicopathologic prognostic factors in CRC have found that stage has the largest effect on survival followed by grade and tumour location, respectively [76].

32 Genetic tumour characteristics CRCs are assumed to develop from adenomas [90], [91]. This development takes place over several years and involves accumulation of genetic alterations [90], [92], [93]. Two major pathways are involved Chromosomal Instability pathway (CIN) or microsatellite stable (MSS) Approximately 80-85% of CRCs result from allelic losses (such as 1p and 8p deletions), chromosomal amplification and translocation (such as loss of heterozygosity of 17p and 18p)[4], [96]. This pathway is called chromosomal instability pathway (CIN) or the microsatellite stable pathway [91]. In this pathway, the genes that have so far been discovered are k-ras (an oncogene), APC, DCC, and p53 (tumour-suppressor genes) [97]-[100], however, more genes are yet to be recognized. MSS tumours have a worse prognosis (average 5-year survival of 54%) than MSI (Microsatellite unstable) tumours (average 5-year survival of 76%) [101], [102] Microsatellite Instability (MSI) The other 10-15% of CRCs observed in large population-based studies [101], [103] occur through a second pathway called microsatellite instability pathway (MSI) [104]. In this pathway, genetic destabilizations results from a loss in DNA mismatch repair function caused by mutation or epigenetic silencing in mismatch repair genes [91]. During cell proliferation, the mismatch occurs most commonly in parts of the DNA with short simple repeated sequences or microsatellites, thus, tumours of the individuals who have lost mismatch repair function have Microsatellite Instability or MSI [91]. MSI is a hallmark of tumours from Hereditary Non- Polyposis CRC (HNPCC families) where some, but not all, of the mutations involved have been identified [44]. In most of the HNPCC families, the genetic basis of the disease is an inherited mutation in mismatch repair (MMR) genes [105]. The mutation in mismatch repair genes is called mutator phenotype [91]. MMR genes are involved in the repair of the mutations that normally occur during DNA replication, and therefore, the mutation in these genes results in persistence of replication errors [106]. Such replication errors, when they occur in oncogenes or tumour suppressor genes, can result in uncontrolled replication of the cells and tumourgenesis [106].

33 16 Five of these genes have been most frequently associated with HNPCC when they are inherited in mutated form; these are hmlh1, hmsh2, hmsh6, hpms1, and hpms2 [91], [107], [108], [109]. Mutation in hmlh1 and hmsh2 account for more than 90% of mutations found in HNPCC families [91]. However, in subjects who meet the familial criteria for HNPCC, genetic mutations are not always identified. Indeed, MLH1 and MSH2 were detected by PCR in only about 50% of the CRCs [110]. These findings raise the possibility that other genes might be involved which have not yet been recognized. In fact, there is evidence suggesting that among those who meet Amsterdam I criteria but in whom no gene mutations have been detected may be different from the recognized HNPCC families [111]. In such cases, it has been shown that the members of these families are at increased for colorectal cancer but not for other HNPCC related cancer sites and therefore, these cases were named Syndrome X as opposed to HNPPCC-Lynch Syndrome [111]. Since 20% of the sporadic CRC tumours contain the same genetic defects, these are considered to happen as a result of epigenetic silencing. The silencing of the mismatch repair genes, usually MLH1, occurs as a result of biallelic or hemiallelic hypermethylation of DNA (referred to as methylator phenotype) [91]. Therefore, there are three distinct groups of genetic alterations in MSI pathway: 1. Mutation in MMR genes among HNPCC families; 2. Mutation in unidentified genes among HNPCC families; 3. Hypermethylation of DNA in MMR genes among sporadic cases. Regardless of whether genetic mutation or epigenetic silencing of MMR genes (mutator or methylator phenotypes) or mutation in unidentified genes are responsible for MSI-H status of the tumour, MSI-H is associated with an overall better prognosis compared to tumours with similar stage and grade but with MSS or MSI-L status [102], [44]. However, it is possible that the pathways from lifestyle factors to MSI-H tumours may be different for familial versus sporadic cases because those who already have mutated mismatch repair genes may develop CRC independent of environment when there is no gene-environment interaction; while those without a previous genetic mutation are more likely to have developed the genetic changes as a result of environment. That is the reason it is important to examine the pathways to MSI status of the tumours considering an indicator of familial susceptibility.

Development of Carcinoma Pathways

Development of Carcinoma Pathways The Construction of Genetic Pathway to Colorectal Cancer Moriah Wright, MD Clinical Fellow in Colorectal Surgery Creighton University School of Medicine Management of Colon and Diseases February 23, 2019

More information

Serrated Polyps and a Classification of Colorectal Cancer

Serrated Polyps and a Classification of Colorectal Cancer Serrated Polyps and a Classification of Colorectal Cancer Ian Chandler June 2011 Structure Serrated polyps and cancer Molecular biology The Jass classification The familiar but oversimplified Vogelsteingram

More information

Colonic Polyp. Najmeh Aletaha. MD

Colonic Polyp. Najmeh Aletaha. MD Colonic Polyp Najmeh Aletaha. MD 1 Polyps & classification 2 Colorectal cancer risk factors 3 Pathogenesis 4 Surveillance polyp of the colon refers to a protuberance into the lumen above the surrounding

More information

Colorectal adenocarcinoma leading cancer in developed countries In US, annual deaths due to colorectal adenocarcinoma 57,000.

Colorectal adenocarcinoma leading cancer in developed countries In US, annual deaths due to colorectal adenocarcinoma 57,000. Colonic Neoplasia Remotti Colorectal adenocarcinoma leading cancer in developed countries In US, annual incidence of colorectal adenocarcinoma 150,000. In US, annual deaths due to colorectal adenocarcinoma

More information

Guidelines for the assessment of mismatch repair (MMR) status in Colorectal Cancer

Guidelines for the assessment of mismatch repair (MMR) status in Colorectal Cancer Guidelines for the assessment of mismatch repair (MMR) status in Colorectal Cancer Start date: May 2015 Review date: April 2018 1 Background Mismatch repair (MMR) deficiency is seen in approximately 15%

More information

FACT SHEET 49. What is meant by a family history of bowel cancer? What is bowel cancer? What causes bowel cancer?

FACT SHEET 49. What is meant by a family history of bowel cancer? What is bowel cancer? What causes bowel cancer? Important points The most important factors that can influence an individual s chance of developing bowel cancer are getting older and having a family history of bowel cancer A family history of bowel

More information

Hereditary Non Polyposis Colorectal Cancer(HNPCC) From clinic to genetics

Hereditary Non Polyposis Colorectal Cancer(HNPCC) From clinic to genetics From clinic to genetics Question 1) Clinical pattern of inheritance of the HNPCC-Syndrome? Question 1) Clinical pattern of inheritance of the HNPCC-Syndrome? Autosomal dominant Question 2) Incidence of

More information

B Base excision repair, in MUTYH-associated polyposis and colorectal cancer, BRAF testing, for hereditary colorectal cancer, 696

B Base excision repair, in MUTYH-associated polyposis and colorectal cancer, BRAF testing, for hereditary colorectal cancer, 696 Index Note: Page numbers of article titles are in boldface type. A Adenomatous polyposis, familial. See Familial adenomatous polyposis. Anal anastomosis, ileal-pouch, proctocolectomy with, in FAP, 591

More information

Colorectal cancer Chapelle, J Clin Oncol, 2010

Colorectal cancer Chapelle, J Clin Oncol, 2010 Colorectal cancer Chapelle, J Clin Oncol, 2010 Early-Stage Colorectal cancer: Microsatellite instability, multigene assay & emerging molecular strategy Asit Paul, MD, PhD 11/24/15 Mr. X: A 50 yo asymptomatic

More information

Content. Diagnostic approach and clinical management of Lynch Syndrome: guidelines. Terminology. Identification of Lynch Syndrome

Content. Diagnostic approach and clinical management of Lynch Syndrome: guidelines. Terminology. Identification of Lynch Syndrome of Lynch Syndrome: guidelines 17/03/2009 Content Terminology Lynch Syndrome Presumed Lynch Syndrome Familial Colorectal Cancer Identification of Lynch Syndrome Amsterdam II criteria Revised Bethesda Guidelines

More information

Trends in colorectal cancer incidence in younger Canadians,

Trends in colorectal cancer incidence in younger Canadians, Trends in colorectal cancer incidence in younger Canadians, 1969-2010 Prithwish De, MHSc, PhD 1,2 ; Parth Patel, MPH 2 1 Surveillance & Ontario Cancer Registry, Cancer Care Ontario 2 Dalla Lana School

More information

Mr Chris Wakeman. General Surgeon University of Otago, Christchurch. 12:15-12:40 Management of Colorectal Cancer

Mr Chris Wakeman. General Surgeon University of Otago, Christchurch. 12:15-12:40 Management of Colorectal Cancer Mr Chris Wakeman General Surgeon University of Otago, Christchurch 12:15-12:40 Management of Colorectal Cancer Bowel cancer Chris Wakeman Colorectal Surgeon Christchurch Sam Simon (Simpsons) Elizabeth

More information

GENETICS OF COLORECTAL CANCER: HEREDITARY ASPECTS By. Magnitude of the Problem. Magnitude of the Problem. Cardinal Features of Lynch Syndrome

GENETICS OF COLORECTAL CANCER: HEREDITARY ASPECTS By. Magnitude of the Problem. Magnitude of the Problem. Cardinal Features of Lynch Syndrome GENETICS OF COLORECTAL CANCER: HEREDITARY ASPECTS By HENRY T. LYNCH, M.D. 1 Could this be hereditary Colon Cancer 4 Creighton University School of Medicine Omaha, Nebraska Magnitude of the Problem Annual

More information

Overview of Cancer. Mylene Freires Advanced Nurse Practitioner, Haematology

Overview of Cancer. Mylene Freires Advanced Nurse Practitioner, Haematology Overview of Cancer Mylene Freires Advanced Nurse Practitioner, Haematology Aim of the Presentation Review basic concepts of cancer Gain some understanding of the socio-economic impact of cancer Order of

More information

COLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer

COLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer COLORECTAL PATHWAY GROUP, MANCHESTER CANCER Guidelines for the assessment of mismatch repair (MMR) status in Colorectal Cancer March 2017 1 Background Mismatch repair (MMR) deficiency is seen in approximately

More information

Microsatellite instability and other molecular markers: how useful are they?

Microsatellite instability and other molecular markers: how useful are they? Microsatellite instability and other molecular markers: how useful are they? Pr Frédéric Bibeau, MD, PhD Head, Pathology department CHU de Caen, Normandy University, France ESMO preceptorship, Barcelona,

More information

COLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer

COLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer COLORECTAL PATHWAY GROUP, MANCHESTER CANCER Guidelines for the assessment of mismatch repair (MMR) status in Colorectal Cancer January 2015 1 Background Mismatch repair (MMR) deficiency is seen in approximately

More information

TumorNext-Lynch. genetic testing for hereditary colorectal or uterine cancer

TumorNext-Lynch. genetic testing for hereditary colorectal or uterine cancer TumorNet-Lynch genetic testing for hereditary colorectal or uterine cancer What Are the Causes of Hereditary Colorectal Cancer? sporadic 70% familial 20% hereditary 10% Lynch syndrome, up to 4% Familial

More information

Familial and Hereditary Colon Cancer

Familial and Hereditary Colon Cancer Familial and Hereditary Colon Cancer Aasma Shaukat, MD, MPH, FACG, FASGE, FACP GI Section Chief, Minneapolis VAMC Associate Professor, Division of Gastroenterology, Department of Medicine, University of

More information

colorectal cancer Colorectal cancer hereditary sporadic Familial 1/12/2018

colorectal cancer Colorectal cancer hereditary sporadic Familial 1/12/2018 colorectal cancer Adenocarcinoma of the colon and rectum is the third most common site of new cancer cases and deaths in men (following prostate and lung or bronchus cancer) and women (following breast

More information

Colorectal Cancer - Working in Partnership. David Baty Genetics, Ninewells Hospital

Colorectal Cancer - Working in Partnership. David Baty Genetics, Ninewells Hospital Colorectal Cancer - Working in Partnership David Baty Genetics, Ninewells Hospital Genetics and Pathology National initiatives Colorectal cancer Inherited CRC Sporadic CRC The Liquid Biopsy The future?

More information

Risk of Colorectal Cancer (CRC) Hereditary Syndromes in GI Cancer GENETIC MALPRACTICE

Risk of Colorectal Cancer (CRC) Hereditary Syndromes in GI Cancer GENETIC MALPRACTICE Identifying the Patient at Risk for an Inherited Syndrome Sapna Syngal, MD, MPH, FACG Director, Gastroenterology Director, Familial GI Program Dana-Farber/Brigham and Women s Cancer Center Associate Professor

More information

Molecular markers in colorectal cancer. Wolfram Jochum

Molecular markers in colorectal cancer. Wolfram Jochum Molecular markers in colorectal cancer Wolfram Jochum Biomarkers in cancer Patient characteristics Tumor tissue Normal cells Serum Body fluids Predisposition Diagnostic marker Specific diagnosis Prognostic

More information

Measure Description. Denominator Statement

Measure Description. Denominator Statement CMS ID/CMS QCDR ID: CAP 18 Title: Mismatch Repair (MMR) or Microsatellite Instability (MSI) Biomarker Testing to Inform Clinical Management and Treatment Decisions in Patients with Primary or Metastatic

More information

Case Presentation Diana Lim, MBBS, FRCPA, FRCPath Senior Consultant Department of Pathology, National University Health System, Singapore Assistant Pr

Case Presentation Diana Lim, MBBS, FRCPA, FRCPath Senior Consultant Department of Pathology, National University Health System, Singapore Assistant Pr Case Presentation Diana Lim, MBBS, FRCPA, FRCPath Senior Consultant Department of Pathology, National University Health System, Singapore Assistant Professor Yong Loo Lin School of Medicine, National University

More information

Colon Cancer and Hereditary Cancer Syndromes

Colon Cancer and Hereditary Cancer Syndromes Colon Cancer and Hereditary Cancer Syndromes Gisela Keller Institute of Pathology Technische Universität München gisela.keller@lrz.tum.de Colon Cancer and Hereditary Cancer Syndromes epidemiology models

More information

FAMILIAL COLORECTAL CANCER. Lyn Schofield Manager Familial Cancer Registry

FAMILIAL COLORECTAL CANCER. Lyn Schofield Manager Familial Cancer Registry FAMILIAL COLORECTAL CANCER Lyn Schofield Manager Familial Cancer Registry Cancer in WA 2004 4000 3500 ASPR, rate per 100,000 3000 2500 2000 1500 1000 Male incidence Female incidence Male mortality Female

More information

COLON CANCER GENETICS (FOR SURGEONS) Mark W. Arnold MD Chief, Division of Colon and Rectal Surgery Professor of Surgery The Ohio State University

COLON CANCER GENETICS (FOR SURGEONS) Mark W. Arnold MD Chief, Division of Colon and Rectal Surgery Professor of Surgery The Ohio State University COLON CANCER GENETICS (FOR SURGEONS) Mark W. Arnold MD Chief, Division of Colon and Rectal Surgery Professor of Surgery The Ohio State University 1. I am a surgeon; of course I have nothing to disclose.

More information

Citation for published version (APA): Bleeker, W. A. (2001). Therapeutic considerations in Dukes C colon cancer s.n.

Citation for published version (APA): Bleeker, W. A. (2001). Therapeutic considerations in Dukes C colon cancer s.n. University of Groningen Therapeutic considerations in Dukes C colon cancer Bleeker, Willem Aldert IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite

More information

The Whys OAP Annual Meeting CCO Symposium September 20. Immunohistochemical Assessment Dr. Terence Colgan Mount Sinai Hospital, Toronto

The Whys OAP Annual Meeting CCO Symposium September 20. Immunohistochemical Assessment Dr. Terence Colgan Mount Sinai Hospital, Toronto Immunohistochemical Assessment of Mismatch Repair Proteins in Endometrial Cancer: The Whys and How Terence J. Colgan, MD Head of Gynaecological Pathology, Mount Sinai Hospital, University of Toronto, Toronto.

More information

Familial and Hereditary Colon Cancer

Familial and Hereditary Colon Cancer Familial and Hereditary Colon Cancer Aasma Shaukat, MD, MPH, FACG, FASGE, FACP GI Section Chief, Minneapolis VAMC Associate Professor, Division of Gastroenterology, Department of Medicine, University of

More information

Colorectal Neoplasia. Dr. Smita Devani MBChB, MRCP. Consultant Physician and Gastroenterologist Aga Khan University Hospital, Nairobi

Colorectal Neoplasia. Dr. Smita Devani MBChB, MRCP. Consultant Physician and Gastroenterologist Aga Khan University Hospital, Nairobi Colorectal Neoplasia Dr. Smita Devani MBChB, MRCP Consultant Physician and Gastroenterologist Aga Khan University Hospital, Nairobi Case History BT, 69yr male Caucasian History of rectal bleeding No change

More information

Multistep nature of cancer development. Cancer genes

Multistep nature of cancer development. Cancer genes Multistep nature of cancer development Phenotypic progression loss of control over cell growth/death (neoplasm) invasiveness (carcinoma) distal spread (metastatic tumor) Genetic progression multiple genetic

More information

M. Azzam Kayasseh,Dubai,UAE

M. Azzam Kayasseh,Dubai,UAE Thanks A Lot Prof. Linda + Prof. Ernst #drkayasseh_crc_rsm #WEO_CRCSC #UEGW17 @dubaiendoscopyforum @drkayasseh.care.to.cure Twenty World Areas Age-Standardized CRC Incidence Rates by Sex GLOBOCAN 2008

More information

A916: rectum: adenocarcinoma

A916: rectum: adenocarcinoma General facts of colorectal cancer The colon has cecum, ascending, transverse, descending and sigmoid colon sections. Cancer can start in any of the r sections or in the rectum. The wall of each of these

More information

LYNCH SYNDROME: IN YOUR FACE BUT LOST IN SPACE (MOUNTAIN)!

LYNCH SYNDROME: IN YOUR FACE BUT LOST IN SPACE (MOUNTAIN)! LYNCH SYNDROME: IN YOUR FACE BUT LOST IN SPACE (MOUNTAIN)! Kathryn Singh, MPH, MS, LCGC Associate Clinical Professor Assistant Director, Graduate Program in Genetic Counseling Division of Genetic and Genomic

More information

Policy Specific Section: Medical Necessity and Investigational / Experimental. October 14, 1998 March 28, 2014

Policy Specific Section: Medical Necessity and Investigational / Experimental. October 14, 1998 March 28, 2014 Medical Policy Genetic Testing for Colorectal Cancer Type: Medical Necessity and Investigational / Experimental Policy Specific Section: Laboratory/Pathology Original Policy Date: Effective Date: October

More information

AllinaHealthSystems 1

AllinaHealthSystems 1 Overview Biology and Introduction to the Genetics of Cancer Denise Jones, MS, CGC Certified Genetic Counselor Virginia Piper Cancer Service Line I. Our understanding of cancer the historical perspective

More information

DIAGNOSTICS ASSESSMENT PROGRAMME Diagnostics consultation document

DIAGNOSTICS ASSESSMENT PROGRAMME Diagnostics consultation document NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE DIAGNOSTICS ASSESSMENT PROGRAMME Diagnostics consultation document Molecular testing strategies for Lynch syndrome in The National Institute for Health

More information

General Surgery Grand Grounds

General Surgery Grand Grounds General Surgery Grand Grounds University of Colorado Health Sciences Center Case Presentation December 24, 2009 Adam Lackey, PGY-5 J.L. - 2111609 27 YO female with chief complaint of abdominal pain. PMHx:

More information

Colonic polyps and colon cancer. Andrew Macpherson Director of Gastroentology University of Bern

Colonic polyps and colon cancer. Andrew Macpherson Director of Gastroentology University of Bern Colonic polyps and colon cancer Andrew Macpherson Director of Gastroentology University of Bern Improtance of the problem of colon cancers - Epidemiology Lifetime risk 5% Incidence/10 5 /annum (US Detroit

More information

Colorectal Cancer Structured Pathology Reporting Proforma DD MM YYYY

Colorectal Cancer Structured Pathology Reporting Proforma DD MM YYYY Colorectal Cancer Structured Pathology Reporting Proforma Mandatory questions (i.e. protocol standards) are in bold (e.g. S1.03). Family name Given name(s) Date of birth DD MM YYYY S1.02 Clinical details

More information

Genetic testing all you need to know

Genetic testing all you need to know Genetic testing all you need to know Sue Clark Consultant Colorectal Surgeon, St Mark s Hospital, London, UK. Colorectal cancer Familial 33% Polyposis syndromes

More information

Yes when meets criteria below. Dean Health Plan covers when Medicare also covers the benefit.

Yes when meets criteria below. Dean Health Plan covers when Medicare also covers the benefit. Genetic Testing for Lynch Syndrome MP9487 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes-as shown below Pre and post test genetic counseling is

More information

Molecular biology of colorectal cancer

Molecular biology of colorectal cancer Molecular biology of colorectal cancer Phil Quirke Yorkshire Cancer Research Centenary Professor of Pathology University of Leeds, UK Rapid pace of molecular change Sequencing changes 2012 1,000 genomes

More information

Célia DeLozier-Blanchet

Célia DeLozier-Blanchet The Genetics Consultation in OB-GYN : Hereditary cancers Célia DeLozier-Blanchet Division of Medical Genetics, Geneva University Hospital It is probable that all cancers are genetic! genetic vs. hereditary

More information

High risk stage II colon cancer

High risk stage II colon cancer High risk stage II colon cancer Joel Gingerich, MD, FRCPC Assistant Professor Medical Oncologist University of Manitoba CancerCare Manitoba Disclaimer No conflict of interests 16 October 2010 Overview

More information

CANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease)

CANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease) CANCER Affects 25% of US population Kills 19% of US population (2nd largest killer after heart disease) NOT one disease but 200-300 different defects Etiologic Factors In Cancer: Relative contributions

More information

Universal Screening for Lynch Syndrome

Universal Screening for Lynch Syndrome Universal Screening for Lynch Syndrome St. Vincent/Ameripath protocol proposal Lynch syndrome (HNPCC) 1/35 individuals with colorectal cancer has Lynch syndrome Over half individuals are >50 at time of

More information

CANCER GENETICS PROVIDER SURVEY

CANCER GENETICS PROVIDER SURVEY Dear Participant, Previously you agreed to participate in an evaluation of an education program we developed for primary care providers on the topic of cancer genetics. This is an IRB-approved, CDCfunded

More information

Caring for a Patient with Colorectal Cancer. Objectives. Poll question. UNC Cancer Network Presented on 10/15/18. For Educational Use Only 1

Caring for a Patient with Colorectal Cancer. Objectives. Poll question. UNC Cancer Network Presented on 10/15/18. For Educational Use Only 1 Caring for a Patient with Colorectal Cancer Tammy Triglianos RN, APRN-BC, AOCNP Nurse Practitioner, GI Oncology 10/15/2018 Objectives Describe common signs and symptoms of colorectal cancer Understand

More information

Pathology perspective of colonic polyposis syndromes

Pathology perspective of colonic polyposis syndromes Pathology perspective of colonic polyposis syndromes When are too many polyps too many? David Schaeffer Head and Consultant Pathologist, Department of Pathology and Laboratory Medicine, Vancouver General

More information

Asingle inherited mutant gene may be enough to

Asingle inherited mutant gene may be enough to 396 Cancer Inheritance STEVEN A. FRANK Asingle inherited mutant gene may be enough to cause a very high cancer risk. Single-mutation cases have provided much insight into the genetic basis of carcinogenesis,

More information

Management of higher risk of colorectal cancer. Huw Thomas

Management of higher risk of colorectal cancer. Huw Thomas Management of higher risk of colorectal cancer Huw Thomas Colorectal Cancer 41,000 new cases pa in UK 16,000 deaths pa 60% 5 year survival Adenoma-carcinoma sequence (Morson) Survival vs stage (Dukes)

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle   holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/1887/22278 holds various files of this Leiden University dissertation. Author: Cunha Carvalho de Miranda, Noel Filipe da Title: Mismatch repair and MUTYH deficient

More information

What All of Us Should Know About Cancer and Genetics

What All of Us Should Know About Cancer and Genetics What All of Us Should Know About Cancer and Genetics Beth A. Pletcher, MD, FAAP, FACMG Associate Professor of Pediatrics UMDNJ- New Jersey Medical School Disclosures I have no relevant financial relationships

More information

COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014

COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014 COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014 WENDY MCKINNON, MS, CGC CERTIFIED GENETIC COUNSELOR FAMILIAL CANCER PROGRAM UNIVERSIT Y OF VERMONT MEDICAL CENTER 1 CHARACTERISTICS

More information

GENETIC MANAGEMENT OF A FAMILY HISTORY OF FAP or MUTYH ASSOCIATED POLYPOSIS. Family Health Clinical Genetics. Clinical Genetics department

GENETIC MANAGEMENT OF A FAMILY HISTORY OF FAP or MUTYH ASSOCIATED POLYPOSIS. Family Health Clinical Genetics. Clinical Genetics department GENETIC MANAGEMENT OF A FAMILY HISTORY OF FAP or MUTYH ASSOCIATED POLYPOSIS Full Title of Guideline: Author (include email and role): Division & Speciality: GUIDELINES FOR THE GENETIC MANAGEMENT OF A FAMILY

More information

Colon Cancer Update Christie J. Hilton, DO

Colon Cancer Update Christie J. Hilton, DO POMA Winter Conference Christie Hilton DO Medical Oncology January 2018 None Colon Cancer Numbers Screening (brief update) Practice changing updates in colon cancer MSI Testing Immunotherapy in Colon Cancer

More information

Current Status of Biomarkers (including DNA Tumor Markers and Immunohistochemistry in the Laboratory Diagnosis of Tumors)

Current Status of Biomarkers (including DNA Tumor Markers and Immunohistochemistry in the Laboratory Diagnosis of Tumors) Current Status of Biomarkers (including DNA Tumor Markers and Immunohistochemistry in the Laboratory Diagnosis of Tumors) Kael Mikesell, DO McKay-Dee Hospital May 14, 2015 Outline Update to DNA Testing

More information

Mismatch Repair Deficiency Testing for Patients with Colorectal Cancer: A Clinical and Cost-Effectiveness Evaluation

Mismatch Repair Deficiency Testing for Patients with Colorectal Cancer: A Clinical and Cost-Effectiveness Evaluation CADTH Optimal Use Report Mismatch Repair Deficiency Testing for Patients with Colorectal Cancer: A Clinical and Cost-Effectiveness Evaluation September 2015 Volume 5, Issue 3a PROSPERO Registration Number:

More information

BowelGene. How do I know if I am at risk? Families with hereditary bowel cancer generally show one or more of the following clues:

BowelGene. How do I know if I am at risk? Families with hereditary bowel cancer generally show one or more of the following clues: BowelGene BowelGene What is hereditary bowel cancer? Bowel cancer (also known as colorectal cancer) is the fourth most common cancer in the UK. Unfortunately 1 in 19 women and 1 in 14 men will develop

More information

ABSTRACT AWARENESS OF COLORECTAL CANCER RISK FACTORS AMONG STUDENTS IN UDAYANA UNIVERSITY, BALI

ABSTRACT AWARENESS OF COLORECTAL CANCER RISK FACTORS AMONG STUDENTS IN UDAYANA UNIVERSITY, BALI ABSTRACT AWARENESS OF COLORECTAL CANCER RISK FACTORS AMONG STUDENTS IN UDAYANA UNIVERSITY, BALI This study aimed to identify the awareness of colorectal cancer risk factors knowledge among medical undergraduates

More information

Research Article Prevalence and Risk Factors of Gastric Adenoma and Gastric Cancer in Colorectal Cancer Patients

Research Article Prevalence and Risk Factors of Gastric Adenoma and Gastric Cancer in Colorectal Cancer Patients Gastroenterology Research and Practice Volume 2016, Article ID 2469521, 7 pages http://dx.doi.org/10.1155/2016/2469521 Research Article Prevalence and Risk Factors of Gastric Adenoma and Gastric Cancer

More information

Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and

Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and private study only. The thesis may not be reproduced elsewhere

More information

Diagnostics guidance Published: 22 February 2017 nice.org.uk/guidance/dg27

Diagnostics guidance Published: 22 February 2017 nice.org.uk/guidance/dg27 Molecular testing strategies for Lynch syndrome in people with colorectal cancer Diagnostics guidance Published: 22 February 2017 nice.org.uk/guidance/dg27 NICE 2018. All rights reserved. Subject to Notice

More information

Introduction to Genetics

Introduction to Genetics Introduction to Genetics Table of contents Chromosome DNA Protein synthesis Mutation Genetic disorder Relationship between genes and cancer Genetic testing Technical concern 2 All living organisms consist

More information

The Next Generation of Hereditary Cancer Testing

The Next Generation of Hereditary Cancer Testing The Next Generation of Hereditary Cancer Testing Why Genetic Testing? Cancers can appear to run in families. Often this is due to shared environmental or lifestyle patterns, such as tobacco use. However,

More information

Bowel cancer screening and prevention

Bowel cancer screening and prevention Bowel cancer screening and prevention Cancer Incidence and Mortality Victoria 2012 Number 6000 5000 4000 3000 2000 Incidences = 29,387 Mortality = 10,780 Incidence Mortality 1000 0 Prostate Breast Bowel

More information

Misheck Ndebele. Johannesburg

Misheck Ndebele. Johannesburg APPLICATION OF THE INFORMATION, MOTIVATION AND BEHAVIOURAL SKILLS (IMB) MODEL FOR TARGETING HIV-RISK BEHAVIOUR AMONG ADOLESCENT LEARNERS IN SOUTH AFRICA Misheck Ndebele A thesis submitted to the Faculty

More information

Introduction. Why Do MSI/MMR Analysis?

Introduction. Why Do MSI/MMR Analysis? Clinical Significance Of MSI, KRAS, & EGFR Pathway In Colorectal Carcinoma UCSF & Stanford Current Issues In Anatomic Pathology Introduction Microsatellite instability and mismatch repair protein deficiency

More information

Colorectal Carcinoma Reporting in 2009

Colorectal Carcinoma Reporting in 2009 Colorectal Carcinoma Reporting in 2009 Overview Colorectal carcinoma- new and confusing AJCC TNM issues Wendy L. Frankel, M.D. Vice-Chair and Director of AP Department of Pathology The Ohio State University

More information

Genetic Testing for Lynch Syndrome

Genetic Testing for Lynch Syndrome Genetic Testing for Lynch Syndrome MP9487 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes-as shown below Pre and post-test genetic counseling is

More information

New Strategy For Treatment Of Hereditary Colorectal Cancer By Shozo Baba

New Strategy For Treatment Of Hereditary Colorectal Cancer By Shozo Baba New Strategy For Treatment Of Hereditary Colorectal Cancer By Shozo Baba If you are looking for a book by Shozo Baba New Strategy for Treatment of Hereditary Colorectal Cancer in pdf form, then you have

More information

Colorectal carcinoma (CRC) was traditionally thought of

Colorectal carcinoma (CRC) was traditionally thought of Testing for Defective DNA Mismatch Repair in Colorectal Carcinoma A Practical Guide Lawrence J. Burgart, MD Context. Significant bench and clinical data have been generated during the last decade regarding

More information

A Review from the Genetic Counselor s Perspective

A Review from the Genetic Counselor s Perspective : A Review from the Genetic Counselor s Perspective Erin Sutcliffe, MS, CGC Certified Genetic Counselor Cancer Risk Evaluation Program INTRODUCTION Errors in base pair matching that occur during DNA replication,

More information

LET S TALK ABOUT CANCER

LET S TALK ABOUT CANCER LET S TALK ABOUT CANCER COLORECTAL CANCER AND CROHN S DISEASE & ULCERATIVE COLITIS crohnsandcolitis.ca BACKGROUND Colorectal cancer is the second-leading cause of cancer death in this country. In 2013,

More information

CANCER Uncontrolled Cell Division

CANCER Uncontrolled Cell Division CANCER Uncontrolled Cell Division What is cancer? Why does it occur? Where does it occur? Benign vs. Malignant? Types of Cancer (3 main groups) There are over 200 different types of cancer 1) Carcinomas

More information

Ovarian Cancer Causes, Risk Factors, and Prevention

Ovarian Cancer Causes, Risk Factors, and Prevention Ovarian Cancer Causes, Risk Factors, and Prevention Risk Factors A risk factor is anything that affects your chance of getting a disease such as cancer. Learn more about the risk factors for ovarian cancer.

More information

LOINC. Clinical information. RCPA code. Record if different to report header Operating surgeon name and contact details. Absent.

LOINC. Clinical information. RCPA code. Record if different to report header Operating surgeon name and contact details. Absent. Complete as narrative or use the structured format below 55752-0 17.02.28593 Clinical information 22027-7 17.02.30001 Record if different to report header Operating surgeon name and contact details 52101004

More information

A DISSERTATION SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY. Helen Mari Parsons

A DISSERTATION SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY. Helen Mari Parsons A Culture of Quality? Lymph Node Evaluation for Colon Cancer Care A DISSERTATION SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY Helen Mari Parsons IN PARTIAL FULFILLMENT

More information

GHUK BowelGene_2017.qxp_Layout 1 22/02/ :22 Page 3 BowelGene

GHUK BowelGene_2017.qxp_Layout 1 22/02/ :22 Page 3 BowelGene GHUK BowelGene_2017.qxp_Layout 1 22/02/2017 10:22 Page 3 BowelGene BowelGene What is hereditary bowel cancer? Bowel cancer (also known as colorectal cancer) is the fourth most common cancer in the UK.

More information

Resource impact report: Molecular testing strategies for Lynch syndrome in people with colorectal cancer (DG27)

Resource impact report: Molecular testing strategies for Lynch syndrome in people with colorectal cancer (DG27) Putting NICE guidance into practice Resource impact report: Molecular testing strategies for Lynch syndrome in people with colorectal cancer (DG27) Published: February 2017 Summary Molecular testing strategies

More information

Is ALS a multistep process?

Is ALS a multistep process? Is ALS a multistep process? Neil Pearce, London School of Hygiene and Tropical Medicine Ammar Al-Chalabi, Institute of Psychiatry, King s College London Zoe Rutter-Locher, King s College London Is ALS

More information

General Session 7: Controversies in Screening and Surveillance in Colorectal Cancer

General Session 7: Controversies in Screening and Surveillance in Colorectal Cancer General Session 7: Controversies in Screening and Surveillance in Colorectal Cancer Complexities of Pathological Assessment: Serrated Polyps/Adenomas Carolyn Compton, MD, PhD Professor of Life Sciences,

More information

For identification, support and follow up related to Familial Gastrointestinal Cancer conditions. South Island Cancer Nurses Network September 2013

For identification, support and follow up related to Familial Gastrointestinal Cancer conditions. South Island Cancer Nurses Network September 2013 For identification, support and follow up related to Familial Gastrointestinal Cancer conditions South Island Cancer Nurses Network September 2013 Who are we? Specialist multidisciplinary team: Nurse coordinators,

More information

BILATERAL BREAST CANCER INCIDENCE AND SURVIVAL

BILATERAL BREAST CANCER INCIDENCE AND SURVIVAL BILATERAL BREAST CANCER INCIDENCE AND SURVIVAL Kieran McCaul A thesis submitted for fulfilment of the requirements for the degree of Doctor of Philosophy Discipline of Public Health Faculty of Health Sciences

More information

Ovarian cancer: 2012 Update Srini Prasad MD Univ Texas MD Anderson Cancer Center

Ovarian cancer: 2012 Update Srini Prasad MD Univ Texas MD Anderson Cancer Center Ovarian cancer: 2012 Update Srini Prasad MD Univ Texas MD Anderson Cancer Center Ovarian cancer is not a single disease Ovarian Epithelial Tumors: Histological Spectrum* Type Frequency Histology High-Grade

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_colon_cancer 5/2004 8/2017 8/2018 8/2017 Description of Procedure or Service Genetic

More information

Lynch Syndrome. Angie Strang, PGY2

Lynch Syndrome. Angie Strang, PGY2 Lynch Syndrome Angie Strang, PGY2 Background Previously hereditary nonpolyposis colorectal cancer Autosomal dominant inherited cancer susceptibility syndrome Caused by defects in the mismatch repair system

More information

The Impact of Family History of Colon Cancer on Survival after Diagnosis with Colon Cancer

The Impact of Family History of Colon Cancer on Survival after Diagnosis with Colon Cancer International Journal of Epidemiology O International Epfdemlotoglcal Association 1995 Vol. 24, No. 5 Printed In Great Britain The Impact of Family History of Colon Cancer on Survival after Diagnosis with

More information

Cancer in Halton. Halton Region Cancer Incidence and Mortality Report

Cancer in Halton. Halton Region Cancer Incidence and Mortality Report Cancer in Halton Halton Region Cancer Incidence and Mortality Report 2008 2012 The Regional Municipality of Halton March 2017 Reference: Halton Region Health Department, Cancer in Halton: Halton Region

More information

Family history and molecular features of children, adolescents, and young adults with colorectal carcinoma

Family history and molecular features of children, adolescents, and young adults with colorectal carcinoma 1146 COLON CANCER Family history and molecular features of children, adolescents, and young adults with colorectal carcinoma C Durno, M Aronson, B Bapat, Z Cohen, S Gallinger... See end of article for

More information

Prior Authorization. Additional Information:

Prior Authorization. Additional Information: Genetic Testing for Lynch Syndrome MP9487 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes-as shown below Pre and post test genetic counseling is

More information

Assessment of Universal Mismatch repair (MMR) or Microsatellite Instability (MSI) testing in colorectal cancers.

Assessment of Universal Mismatch repair (MMR) or Microsatellite Instability (MSI) testing in colorectal cancers. Assessment of Universal Mismatch repair (MMR) or Microsatellite Instability (MSI) testing in colorectal cancers. Soheila Hamidpour MD, Madhusudhana S MD. MMR deficient colorectal tumors can be present

More information

Guidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer

Guidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer s on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer Francis M. Giardiello, MD, 1 John I. Allen, 2 Jennifer E. Axilbund,

More information

Anatomic Molecular Pathology: An Emerging Field

Anatomic Molecular Pathology: An Emerging Field Anatomic Molecular Pathology: An Emerging Field Antonia R. Sepulveda M.D., Ph.D. University of Pennsylvania asepu@mail.med.upenn.edu 2008 ASIP Annual Meeting Anatomic pathology (U.S.) is a medical specialty

More information

Agenda 8:30 AM. Jennifer L. Hunt

Agenda 8:30 AM. Jennifer L. Hunt Agenda Topic Introduction Terence J. Colgan Jennifer L. Hunt Time 8:30 AM Pre-analytic Variables in Molecular Testing Philip A. Branton 8:40 AM Carcinoma of Unknown Primary Site Is Gene Expression Profiling

More information

National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation Annual Progress Report: 2009 Formula Grant

National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation Annual Progress Report: 2009 Formula Grant National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation Annual Progress Report: 2009 Formula Grant Reporting Period July 1, 2012 June 30, 2013 Formula Grant Overview The National Surgical

More information

Genetic Testing for Lynch Syndrome and Inherited Intestinal Polyposis Syndromes

Genetic Testing for Lynch Syndrome and Inherited Intestinal Polyposis Syndromes Genetic Testing for Lynch Syndrome and Inherited Intestinal Polyposis Syndromes Policy Number: 2.04.08 Last Review: 1/2014 Origination: 1/2004 Next Review: 1/2015 Policy Blue Cross and Blue Shield of Kansas

More information